UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 2007-05, Vol.25 (15), p.1960-1966

2007

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.49-55

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2282-2292

2001

Link zum Volltext

Verfügbarkeit prüfen

Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study

Journal of pain and symptom management, 2008-04, Vol.35 (4), p.420-429

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14

Journal of clinical oncology, 2011-10, Vol.29 (29), p.3869-3876

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2300-2308

1999

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

The lancet oncology, 2013, Vol.14 (1), p.72-80

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Docetaxel for Node-Positive Breast Cancer

The New England journal of medicine, 2005-06, Vol.352 (22), p.2302-2313

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer

Investigational new drugs, 2012-04, Vol.30 (2), p.779-786

2012

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer

Clinical lung cancer, 2003-09, Vol.5 (2), p.107-112

2003

Link zum Volltext

Verfügbarkeit prüfen

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

British journal of haematology, 2007-01, Vol.136 (2), p.203-211

2007

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy

Supportive care in cancer, 1995-09, Vol.3 (5), p.307-312

1995

Link zum Volltext

Verfügbarkeit prüfen

Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline

Lung cancer (Amsterdam, Netherlands), 2005-12, Vol.50 (3), p.355-374

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1174-1178

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy

Journal of clinical oncology, 1997-08, Vol.15 (8), p.2966-2973

1997

Link zum Volltext

Verfügbarkeit prüfen

P1-249: Anemia rates in completely resected non-small cell lung cancer (NSCLC) patients receiving adjuvant chemotherapy; An interim analysis

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S837-S838

2007

Link zum Volltext

Verfügbarkeit prüfen

O-153 Results of a phase II trial of EGF-P64 vaccine in patients with

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S47-S47

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen

Clinical cancer research, 1995-03, Vol.1 (3), p.287

1995

Link zum Volltext

Verfügbarkeit prüfen

Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

Oncology, 1999-01, Vol.56 (2), p.114-121

1999

Link zum Volltext

Verfügbarkeit prüfen

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

European heart journal, 2016-10, Vol.37 (39), p.2999-3058

2016

Link zum Volltext

Verfügbarkeit prüfen

Ecology of the wood turtle, Clemmys insculpta, Quebec, Canada

Walde, Andrew David

1998

Link zum Volltext
ProQuest

From self-assembled vesicles to protocells

Cold Spring Harbor perspectives in biology, 2010-07, Vol.2 (7), p.a002170-a002170

2010

Link zum Volltext

Verfügbarkeit prüfen

BIF-hosted iron mineral system: A review

Ore geology reviews, 2016-07, Vol.76, p.317-359

2016

Link zum Volltext

Verfügbarkeit prüfen

Hyperosmolar Non-ketotic Diabetic Coma: With Particular Reference to Vascular Complications

BMJ, 1971-01, Vol.1 (5740), p.85-86

1971

Link zum Volltext

Verfügbarkeit prüfen

Dual, Site‐Specific Modification of Antibodies by Using Solid‐Phase Immobilized Microbial Transglutaminase

Chembiochem : a European journal of chemical biology, 2017-10, Vol.18 (19), p.1923-1927

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(56)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(36)
Humans
(21)
Female
(18)
Biological And Medical Sciences
(16)
Middle Aged
(16)
Medical Sciences
(15)
Oncology
(14)
Male
(13)
Aged
(12)
Adult
(10)
Treatment Outcome
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Chemotherapy
(8)
Aged, 80 And Over
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Ecology
(6)
Medicin Och Hälsovetenskap
(6)
Administration, Oral
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Tetrodotoxin for Moderate to Severe Cancer Pain: A Randomized, Double Blind, Parallel Design Multicenter Study

Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

Adjuvant Docetaxel for Node-Positive Breast Cancer

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer

A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer

A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7

Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy

Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy

Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy

P1-249: Anemia rates in completely resected non-small cell lung cancer (NSCLC) patients receiving adjuvant chemotherapy; An interim analysis

O-153 Results of a phase II trial of EGF-P64 vaccine in patients with

Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen

Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Ecology of the wood turtle, Clemmys insculpta, Quebec, Canada

From self-assembled vesicles to protocells

BIF-hosted iron mineral system: A review

Hyperosmolar Non-ketotic Diabetic Coma: With Particular Reference to Vascular Complications

Dual, Site‐Specific Modification of Antibodies by Using Solid‐Phase Immobilized Microbial Transglutaminase

Suchergebnisse filtern